Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Liver Cancer > Volume 15(2); 2015 > Article
Case Report Two Cases of Early Recurred Hepatocellular Carcinoma after Surgical Resection Which Showed Different Outcomes
Young Youn Cho1, Jeong-Hoon Lee1, Nam Joon Yi2, Kwang Woong Lee2, Kyung Suk Suh2, Yoon Joon Kim1, Jung-Hwna Yoon1
Journal of Liver Cancer 2015;15(2):126-131
DOI: https://doi.org/10.17998/jlc.15.2.126
Published online: September 30, 2015
1Departments of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul,
2Departments of Surgery, Seoul National University College of Medicine, Seoul, Korea
Corresponding author:  Jeong-Hoon Lee,
Email: pindra@empas.com
  • 802 Views
  • 6 Download
  • 0 Crossref
  • 0 Scopus

Hepatocellular carcinoma (HCC) has poor prognosis, even after curative resection. Early recurrence after curative treatment is a major cause of the poor prognosis. Pathologic factors such as vessel invasion, satellite nodule, size of tumor and pathologic grade are prognostic factors predicting early recurrence and poor prognosis. We share our experience of two
case
s which both showed early recurrence after curative hepatic resection, but eventually demonstrated different prognosis. Since the most common cause of death after potentially curative treatment is tumor recurrence, suppression of tumor recurrence might be linked to survival gain. Currently, there is no adjuvant therapy for HCC endorsed by international guidelines. However, recent studies have shown that antiviral treatment for hepatitis B virusrelated HCC and immunotherapy using autologous cytokine-induced killer cell reduced HCC recurrence. Further study is needed to select patients who will benefit from adjuvant treatments.


JLC : Journal of Liver Cancer